Home » Authors » James Etheridge

Articles by James Etheridge

Cellectis Wins Patent Battle for Gene-Targeting Process

Feb. 27, 2008

By James Etheridge

Immtech Drops Pafuramidine Due to Liver Safety Concerns

Feb. 27, 2008

By James Etheridge

Cellectis Wins Patent Battle for Gene-Targeting Process

Feb. 27, 2008

By James Etheridge

Boost in French Funding Gives Innate 68% Revenue Increase

Feb. 13, 2008

By James Etheridge

Trophos Awarded Grant for Parkinson's Work

Feb. 13, 2008

By James Etheridge

Boost in French Funding Gives Innate 68% Revenue Increase

Feb. 13, 2008

By James Etheridge

Trophos Awarded Grant for Parkinson's Work

Feb. 13, 2008

By James Etheridge

Innate Pharma, Novo Nordisk Refocus Efforts on Inflammation

Feb. 6, 2008

By James Etheridge

Polyplus-transfection Produces Nucleic Acid Transfer Agent

Feb. 6, 2008

By James Etheridge

Polyplus-transfection Produces Nucleic Acid Transfer Agent

Feb. 6, 2008

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld Science
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...